CEO-Talk: Sijmen de Vries (Pharming)

from Beurs en beleggen podcast De Aandeelhouder · host De AandeelHouder - Nico Inberg, Albert Jellema in gesprek met beleggingsexperts

In deze aflevering ontvangt Nico Inberg de CEO van Pharming: Sijmen de Vries. De heren bespreken de ontwikkelingen omtrent Joenja (leniolisib), de stand van zaken bij Ruconest en natuurlijk ook de halfjaarcijfers en de vooruitzichten van de onderneming. Bovendien komen de ingestuurde vragen van beleggers aan bod in de Q&A

Episode metadata supplied by the publisher feed · Published Aug 8, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

CEO-Talk: Sijmen de Vries (Pharming)

0:00 1:23:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Beurs en beleggen podcast De Aandeelhouder?

This episode is 1 hour and 23 minutes long.

When was this Beurs en beleggen podcast De Aandeelhouder episode published?

This episode was published on August 8, 2023.

Can I download this Beurs en beleggen podcast De Aandeelhouder episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!